EUR 6.1
(1.67%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 107.64 Million EUR | 1.12% |
2022 | 106.45 Million EUR | -23.45% |
2021 | 139.06 Million EUR | -5.24% |
2020 | 146.75 Million EUR | 3.49% |
2019 | 141.81 Million EUR | 16.75% |
2018 | 121.46 Million EUR | -1.36% |
2017 | 123.13 Million EUR | 1.43% |
2016 | 121.4 Million EUR | 49.78% |
2015 | 81.05 Million EUR | -9.58% |
2014 | 89.64 Million EUR | -10.06% |
2013 | 99.66 Million EUR | 12.76% |
2012 | 88.38 Million EUR | 8.05% |
2011 | 81.8 Million EUR | 12.26% |
2010 | 72.87 Million EUR | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 Q4 | 107.64 Million EUR | 0.0% |
2023 Q2 | 110.9 Million EUR | 0.0% |
2022 FY | 106.45 Million EUR | -23.45% |
2022 Q2 | 139.28 Million EUR | 0.0% |
2022 Q4 | 106.47 Million EUR | 0.0% |
2021 Q2 | 144.1 Million EUR | 0.0% |
2021 Q4 | 139.06 Million EUR | 0.0% |
2021 FY | 139.06 Million EUR | -5.24% |
2020 Q4 | 146.75 Million EUR | 0.0% |
2020 Q2 | 151.08 Million EUR | 0.0% |
2020 FY | 146.75 Million EUR | 3.49% |
2019 Q4 | 141.81 Million EUR | 0.0% |
2019 Q2 | 123.98 Million EUR | 0.0% |
2019 FY | 141.81 Million EUR | 16.75% |
2018 FY | 121.46 Million EUR | -1.36% |
2018 Q4 | 121.46 Million EUR | 0.0% |
2018 Q2 | 124.37 Million EUR | 0.0% |
2017 Q2 | 124.42 Million EUR | 0.0% |
2017 FY | 123.13 Million EUR | 1.43% |
2017 Q4 | 123.12 Million EUR | 0.0% |
2016 Q4 | 121.66 Million EUR | 0.0% |
2016 FY | 121.4 Million EUR | 49.78% |
2016 Q2 | 115.66 Million EUR | 0.0% |
2015 Q2 | 72.53 Million EUR | 0.0% |
2015 Q4 | 81.62 Million EUR | 0.0% |
2015 FY | 81.05 Million EUR | -9.58% |
2014 FY | 89.64 Million EUR | -10.06% |
2014 Q4 | 89.64 Million EUR | 0.0% |
2014 Q2 | 134.88 Million EUR | 0.0% |
2013 Q4 | 99.66 Million EUR | 0.0% |
2013 FY | 99.66 Million EUR | 12.76% |
2012 FY | 88.38 Million EUR | 8.05% |
2011 FY | 81.8 Million EUR | 12.26% |
2010 FY | 72.87 Million EUR | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Crossject Société Anonyme | 16.18 Million EUR | -564.952% |
Safe Orthopaedics SA | 9.43 Million EUR | -1041.075% |
Spineway SA | 2.6 Million EUR | -4037.164% |
Sartorius Stedim Biotech S.A. | 3.68 Billion EUR | 97.076% |
EssilorLuxottica Société anonyme | 11.65 Billion EUR | 99.077% |
bonyf N.V. | 75 Thousand EUR | -143432.0% |